2CI0 | Oxidoreductase | date | Mar 16, 2006 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | High Throughput Screening And X-Ray Crystallography Assisted Evaluation Of Small Molecule Scaffolds For Cyp51 Inhibitors | ||||||||||||||
authors | L.M.Podust, Y.Kim, L.V.Yermalitskaya, J.P.Von Kries, M.R.Waterma | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Cytochrome P450 51 Chain: A Synonym: Sterol 14alpha-Demethylase Cyp51, Ypli, P450-Lia1, 14-Alpha Demethylase, Lanosterol 14-Alpha Demethylase, P450 Ec: 1.14.13.70 Engineered: Yes Mutation: Yes Other_details: 4xhis Tag At The C-Terminus |
Organism_scientific: Mycobacterium Tuberculosis Organism_taxid: 83332 Strain: H37rv Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Hms174(De3) Expression_system_vector: Pet Expression_system_plasmid: Pet17b | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.53 Å | ||||||||||||
ligand | 1CM, HEM BindingDB | enzyme | Oxidoreductase E.C.1.14.13.70 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Small Molecule Scaffolds for CYP51 Inhibitors Identified by High Throughput Screening and Defined by X-Ray Crystallography., Podust LM, von Kries JP, Eddine AN, Kim Y, Yermalitskaya LV, Kuehne R, Ouellet H, Warrier T, Altekoster M, Lee JS, Rademann J, Oschkinat H, Kaufmann SH, Waterman MR, Antimicrob Agents Chemother. 2007 Sep 10;. PMID:17846131 |
Data retrieval |
View 2CI0 in 3D |
Visual 3D analysis of 2CI0 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2CI0 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |